Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: DAX (0.42%) to 24261.59, CAC40 (1.64%) to 7839.02, STOXX 600 (0.46%) to 558.70

Aug 25 ,2025

  • Synopsis:

    • European indices ended mostly lower. FTSE closed for Bank Holiday. Follows positive performance on Friday, with Stoxx 600 extending gains for the third consecutive week. In sectors, media, travel/leisure holding up better, while constructions and utilities the main laggards.

    • Focus on less dovish ECB talk with Kazaks and Rehn suggesting no urgency to cut rates further. More skepticism on EU/US trade deal, with reports suggesting violation of WTO principles of reciprocity and non discrimination. ECB's President Lagarde said tariffs may only have a small effect on Europe's GDP; companies will adjust to higher US tariffs. BoE Governor Bailey flagged UK's economic challenges, citing weak growth and post-pandemic workforce decline. Economists cautioned Chancellor Reeves' tax-and-spend policies risk 1970s-style debt crisis.

    • Light on the data front. Germany August IFO Business Climate improves slightly to 89.0 vs consensus 88.7 and prior 88.6, Current Conditions worsens to 86.4 vs consensus 86.7 and prior 86.5 while Expectations firmer to 91.6 vs consensus 90.2 vs prior revised 90.8 from 90.7. Also, Spanish producer prices up by +0.3% in July vs consensus +1.0% and prior +0.8%. Swiss employment up +0.6% in Q2.

    • In corporate news, US ordered Orsted (ORSTED.DC) to halt Revolution Wind project over national security concerns, which could could raise costs, affect PPAs, and postpone planned capital increase. Group confirmed commitment to proceed with previously announced DKK60B rights issue; appoints consortium of banks. Henkel (HEN3.GR) CEO said in an interview with Rheinische Post to anticipate profitable growth this fiscal year; does not expect widespread price increases like in 2022.

    • On the M&A newsflow, Keurig Dr Pepper (KDP) reportedly close to a ~ $18B deal to buy JDE Peet (JDEP.NA). Unicredit (UCG.IM) has converted into shares part of its synthetic position in Commerzbank (CBK.GR) to total ~26% physical equity stake; the remaining synthetic position should be converted into physical shares in due course taking it total equity voting stake in Commerzbank to ~29%.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, France Aug consumer confidence, Sweden Jul PPI and Finland Jul unemployment rate.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Media +0.63%, Travel & Leisure +0.31%, Food & Beverage +0.13%, Basic Resources +0.13%, Financial Svcs +0.12%, Health Care +0.02%, Banks (0.04%), Ind Goods & Svcs (0.12%), Technology (0.13%)

      • Underperformers:

        • Construct & Mtls (1.17%), Utilities (0.99%), Real Estate (0.45%), Autos & Parts (0.39%), Chemicals (0.36%), Oil & Gas (0.30%), Telecom (0.28%), Insurance (0.25%), Persnl & HHold Goods (0.24%), Retail (0.23%)

    • Macro:

      • Central Banks:

        • Euro Zone Can Handle Higher US Tariffs, ECB's Lagarde Tells Fox -- Bloomberg

      • EU:

        • What's the EU For? Its Leaders Need a Better Answer -- Bloomberg

      • UK:

        • UK migrant arrivals on small boats reach new record -- Reuters

        • Get ready for fracking, Reform UK tells energy firms -- BBC

        • Reeves's inflation headache is of her own making -- Telegraph

      • Germany:

        • Germany's pensions crisis: can €10 a month change how people invest? -- FT

      • France:

        • Economic growth in France stalls amid weak business confidence -- interiordaily

      • Ireland:

        • Government Action Plan on Market Diversification -- Gov.IE

        • The Daft.ie Rental Price Report -- Daft.ie

      • Switzerland:

        • Nervous Swiss ready Trump sweetened offer for tariff pain relief -- Reuters

      • Greece:

      • Norway:

        • Election opinion poll -- TV2

    • Company news:

      • Notable Gainers

        • +27.9% HLEE.SW (Highlight Event & Entertainment) Highlight Communications majority holder HLEE to carry out capital increase by which new investor may acquire majority stake in HLEE

        • +17.3% JDEP.NA (JDE Peet) -- Keurig Dr Pepper to acquire JDE Peet for €31.85/share in cash

        • +6.2% OKEA.NO (Okea) -- announces oil discoveries in the Talisker exploration well at the Brage field PL 055

        • +2.8% ARGX.BB (argenx) -- pivotal ADAPT SERON study of VYVGART meets primary endpoint

        • +1.8% INLOT.GA (Intralot) -- Bally's announces mandatory tender offer for Intralot becomes unconditional (22-Aug)

        • +1.5% SOFF.NO (Solstad Offshore) -- wins two contract extensions for vessels; combined value ~$65M

        • +1.4% TGS.NO (TGS-NOPEC Geophysical Co.) -- announces the award of a large streamer contract offshore Indonesia

        • +1.3% ESSITY.B.SS (Essity) -- Dagens Industri out with buy recommendation for Essity (23-Aug)

        • +0.9% CVC.NA (CVC.NA) -- Bain, Axight could join forces to bid for La Trobe Financial; CVC among other competing suitors - Australian Financial Review

      • Notable Decliners

        • -0.2% BOL.SS (Boliden) -- District Metals Corp. announces Boliden decides to terminate the earn-in and JV agreement on the Tomtebo and Stollberg base metal polymetallic properties

        • -1.0% METN.SW (Metall Zug) -- H1 net income (CHF10.3M) vs FactSet (CHF1.4M) [1 est]

        • -1.5%PARKEN.DC (PARKEN Sport & Entertainment) -- reports Q2 EPS (DKK1.43) vs year-ago DKK5.90; reaffirms FY guidance

        • -2.1% OSE.FP (OSE Immunotherapeutics) -- proposes governance evolution and reaffirms strategic priorities; announces roadmaps for Tedopi and Lusvertikimab

        • -16.0% ORSTED.DC (Ørsted) -- US orders Revolution Wind project to stop construction

        • -21.7% VLA.FP (Valneva) -- announces FDA's decision to suspend license of Chikungunya Vaccine IXCHIQ in the U.S.

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: DEME Group (DEME.BB), Banqup Group (BANQ.BB)

        • Denmark: Royal Unibrew (RBREW.DC), Vestjysk Bank (VJBA.DC), Fynske Bank (FYNBK.DC)

        • Germany: Dermapharm Holding (DMP.GR), SFC Energy (F3C.GR), Green Hydrogen Systems (3LUA.GR)

        • Norway: Bakkafrost (BAKKA.NO), BW LPG (BWLPG.NO), Cadeler (CADLR.NO), MPC Container Ships (MPCC.NO), Grieg Seafood (GSF.NO), Bouvet (BOUV.NO), Paratus Energy Services (PLSV.NO), Capsol Technologies (CAPSL.NO), Dolphin Drilling (DDRIL.NO)

        • Other: Moscow Exchange (MOEX.RU)

        • Sweden: BioInvent International (BINV.SS), Eolus (EOLU.B.SS), AlzeCure Pharma (ALZCUR.SS), Xbrane Biopharma (XBRANE.SS)

        • Switzerland: Flughafen Zuerich (FHZN.SW), TX Group (TXGN.SW), VP Bank (VPBN.SW), Arbonia (ARBN.SW), Kudelski (KUD.SW)

        • UK: Prudential (PRU.LN), Ashtead Technology Holdings (AT.LN)

  • Data:

    • Economics:

      • Germany Aug IFO

        • Business Climate 89.0 vs consensus 88.7 and prior 88.6

        • Current Conditions 86.4 vs consensus 86.7 and prior 86.5

        • Expectations 91.6 vs consensus 90.2 vs prior revised 90.8 from 90.7

      • Spain Jul PPI +0.3% y/y vs consensus +1.0% and prior +0.8%

      • Finland Jul PPI (1.5%) vs consensus (2.0%) and prior (1.8%)

    • Markets:

      • WTI Crude (Oct 25): +$1.06 or +1.67% to $64.72

      • €-$ (0.0042) or (0.36%) to 1.1685

      • £-$ (0.0026) or (0.19%) to 1.3499

      • €-£ (0.0012) to 0.8658

      • S&P 500 (0.04%)

      • Performance year-to-date

        • FTSE 100: +14.05%

        • DAX: +21.86%

        • CAC: +6.21%

        • MIB: +26.48%

        • Stoxx 600: +10.07%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE